Zai Lab Limited
Sector: Manufacturing
Industry: Pharmaceutical Products
32.59
-0.04
(-0.12%)
Volume:
835,782
52 week range:
16.01 - 39.77
Market Cap:
51.218B
Company Description:
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia. It also develops Odronextamab, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer